Cuenta de resultados
Ventas 54.304M vs 46.881M +15%. EBITDA normalizado 19.209M +11,8%. Margen 35% -118p. Beneficio neto 5.774M vs 5.022M +14%. EPS underlying 2,88 vs 2,51 +14%
2022 Outlook
- EBITDA between 4-8% and our revenue to grow ahead of EBITDA
- Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 170 to 200 million USD per quarter
- The average gross debt coupon in FY22 to be approximately 4.0%.
- Capital expenditure of between 4.5 and 5.0 billion USD in FY22.
Deuda
Our net debt decreased to 76.2 billion USD as of 31 December 2021 from 82.7 billion USD as of 31 December 2020. 95Bn en 2019.
Our net debt to normalized EBITDA ratio was 3.96x as of 31 December 2021. Our optimal capital structure is a net debt to normalized EBITDA ratio of around 2x.
No tienen grandes pagos de deuda a corto plazo. La mayor parte de la deuda alcanza más de 5 años.
Según la cuenta de resultados. Los costes financieros pasan de 5.959M en 2020 a 4.803M en 2021.
Si desglosamos, vemos que “net interest expense” ha pasado de -3.854M a -3.561M, mientras la partida “mark-to-market” ha pasado de -1.211M a -23M.
En relación a esto tenemos que tener en cuenta dos aspectos:
- Net interest expense in FY21 reduced by 293 million USD, primarily due to lower gross debt balances.
- Non-underlying net finance income/(cost) -1.738M en 2020 vs -806M en 2021.
Flujos de caja
- El FCO antes de circulante alcanza los 18.806M vs 17.171M de 2020, +9,5%.
- FCO 14.799M (77% EBITDA) vs 10.891M.
- El CAPEX sube a -5.498M vs -3.687M
- Dividendos -2.364M.
Cotización
A 55 euros tiene un EV de 187205, lo que da un EV/EBITDA 9,7
Dejar un comentario: